Shannon L. Maude, MD, PhD, highlighted promising long-term disease-free survival and MRD negativity with tisagenleucel in high-risk pediatric ALL.
Shannon L. Maude, MD, PhD
Advertisement
Shannon L. Maude, MD, PhD, is an attending physician in the Cancer Center at the Children’s Hospital of Philadelphia.
Articles by Shannon L. Maude, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Led to Declines in Immunoglobulins in Patients With MS
2
Orca-T Gains FDA Approval for Matched Donor Stem Cell Transplant
3
House Panel Advances Bills to Expand Veterans’ Health Care Access
4
Racial Gaps in Cancer Pain Management Persist in Community Care: Ila Sruti, MPH
5